SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories incorporates wholly owned subsidiary in UAE

20 May 2024 Evaluate

Ind-Swift Laboratories has incorporated wholly owned subsidiary (WOS) in the name and style of ‘ISLL Middle East L.L.C-FZ’ in Dubai, United Arab Emirates (UAE). The certificate of incorporation has been received on May 17, 2024 from the Registrar of Companies of the Meydan - Free Zone.

The WOS intends to strategically invest in pharmaceutical and allied activities. This includes exploring potential acquisitions, tie-ups, or joint ventures. Additionally, the Company aims to establish and operate pharmaceutical manufacturing units.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).


Ind-Swift Lab. Share Price

139.40 1.40 (1.01%)
11-May-2026 12:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1875.35
Dr. Reddys Lab 1299.30
Cipla 1317.65
Zydus Lifesciences 944.35
Lupin 2267.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×